Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Flowserve Corporation Common Stock (FLS) vs TransMedics Group Inc (TMDX) Price & Performance

Flowserve Corporation Common StockTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Flowserve Corporation Common Stock vs TransMedics Group Inc — how do they compare? Flowserve Corporation Common Stock trades at $71.39 (market cap $8.85B), while TransMedics Group Inc trades at $77.31 (market cap $2.74B). The key difference: Flowserve Corporation Common Stock is far larger — about 3.2× TransMedics Group Inc's market cap, and Flowserve Corporation Common Stock pays a 1.26% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 0 Days and TransMedics Group Inc for 24 Days on average.

FLSTMDX
Market Cap
$8.85B$2.74B
Volume
1,955,324949,331
Sector
IndustrialsHealth
52-Week High
$92.04$150.42
52-Week Low
$49.09$61.99
Typical Hold Time
0 Days24 Days
Enterprise Value
$10.44B$3.13B
Dividend Yield
1.26%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Flowserve Corporation Common Stock

No Aura AI signal available yet.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.

The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLS
100% Buy0% Sell
Avg holding period · 0 Days
TMDX
100% Buy0% Sell
Avg holding period · 24 Days

About Flowserve Corporation Common Stock

Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.

Read more on FLS →

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX →